Bone Biologics Corp
BBLG· Nasdaq
BBLGBone Biologics Corp
Filed Aug 15, 2016 · 10-Q · 46 days after period end · 0001493152-16-012301
| Metric | Q2 2016 | Q2 2015 | Q2 2014 | Q2 2012 |
|---|---|---|---|---|
| Net Income | -$4.70M | -$890.80K | -$427.57K | -$2.15K |
| EPS Diluted | -$0.13 | -$0.03 | -$0.04 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Bone Biologics Corp · CIK 1419554 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 15, 2016 · 46 d after period end
